Eikon Therapeutics Inc. Common Stock
EIKN | NASDAQ
$5.31
-$0.04 (-0.75%)
At close: Oct 30, 2026, 4:00 PM ET
$5.49
+$0.18 (+3.39%)
Pre-market:
Nov 2, 2026, 4:00 AM ET
Fiscal Year Period Ending | FY 2025 Dec 31, 2025 |
|---|---|
Net Income | -324.25M |
Depreciation & Amortization | 24.18M |
Stock-Based Compensation | 18.04M |
Other Working Capital | 81.65M |
Other Non-Cash Items | 15.69M |
Deferred Income Tax | n/a |
Change in Working Capital | 77.84M |
Operating Cash Flow | -188.52M |
Capital Expenditures | -46.74M |
Cash Acquisitions | n/a |
Purchase of Investments | -444.1M |
Sales Maturities Of Investments | 309.5M |
Other Investing Acitivies | n/a |
Investing Cash Flow | -181.34M |
Debt Repayment | n/a |
Common Stock Repurchased | n/a |
Dividend Paid | n/a |
Other Financial Acitivies | n/a |
Financial Cash Flow | 352.05M |
Net Cash Flow | -17.81M |
Free Cash Flow | -235.26M |
Adj. Free Cash Flow | -253.29M |
Maintenance CapEx | -24.18M |
Growth CapEx | -22.57M |
Owner Earnings | -212.69M |
Add to Watchlist
Select watchlists to add or remove EIKN